BSEAGM/EGM1d ago · 17 Nov 2026, 06:17 pm

Voting Results and Scrutinizer Report of Postal Ballot notice dated 14th October 2026

Fischer Medical Ventures Ltd · 524743

✦ AI SummaryResults

Fischer Medical Ventures Ltd has announced the voting results and scrutinizer report of its postal ballot notice dated 14th October 2026. The shareholders have approved resolutions 1, 3, 6, and 7 with the requisite majority. The resolutions pertain to the creation of security by way of first-ranking pari passu floating charge over the company's Indian material subsidiaries, related party transactions, and corporate guarantees.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk6/10
Balance Sheet Risk8/10
Liquidity Impact4/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fischer Medical Ventures Ltd - 524743 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Attachments (1)

📄

87da1454-fa07-4e1c-973e-3b5e1d779748.pdf

pdf

Download →
View document text
FISCHER MEDICAL VENTURES LIMITED Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 November 17, 2026 To To BSE Limited National Stock Exchange of India Ltd. Exchange Corporate Relationship Department Plaza, 5tll floor 25th Floor, P J Towers Plot No. C/ 1, G Block, Dalal Street, Fort, Bandra-Kurla Complex Bandra (E), Mumbai – 400 001 Mumbai - 400 051 BSE Scrip Code: 524743 NSE Symbol: FISCHER Dear Sir / Madam, Reg : Intimation of the results of Postal Ballot as per Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI (LODR) 2015) Please refer to our letter dated 14th October 2026, informing about the proposal to seek the approval of the shareholders of the Company by way of ordinary and special resolutions, through postal ballot (e- voting) for the following Special Business: a) Approval for creation of security by way of first-ranking pari passu floating charge over the present and future assets of the company’s Indian material subsidiaries in connection with the proposed issuance of senior, secured, rated, listed, redeemable, taxable, transferable non-convertible debentures. b) Approval for related party transaction in connection with the proposed pledge of equity shares of the company held by the promoters and/or holding company/promoter group company as security for the proposed issuance of senior, secured, rated, listed, redeemable, taxable, transferable non- convertible debentures. c) Approval for creation of pledge over 100% of the equity shares held by the company in its key subsidiaries (Indian material subsidiaries) in connection with the proposed issuance of senior, secured, rated, listed, redeemable, taxable, transferable non-convertible debentures. d) Approval for obtaining corporate guarantee from the promoter/ holding company FMV Holdings Pte. Ltd. In connection with the proposed issuance of senior, secured, rated, listed, redeemable, taxable, transferable non-convertible debentures. e) Approval for obtaining corporate guarantee from promoter group company Mercatus Capital Pte. Ltd. in connection with the proposed issuance of senior, secured, rated, listed, redeemable, taxable, transferable non-convertible debentures. f) Power to create charge on the assets of the company to secure borrowings pursuant to Section 180(1)(a) of The Companies Act, 2013. g) Increase in Borrowing limit pursuant to section 180(1)(c) of The Companies Act, 2013. Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006 FISCHER MEDICAL VENTURES LIMITED Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 Please find enclosed the details of the result of the said Postal Ballot together with the particulars of the voting thereon as required under Clause 44 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. Also, please find attached the Scrutinizer's Report dated 17th November, 2026 pursuant to Section 110 of the Companies Act, 2013 read with Rule 22 of the Companies (Management and Administration) Rules, 2014. We also wish to inform you that the resolutions 1, 3, 6 and 7 have been approved by the shareholders with requisite majority. Thanking You, Yours Truly, For FISCHER MEDICAL VENTURES LIMITED BALAJI GANDLA COMPANY SECRETARY & COMPLIANCE OFFICER Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006 NUREN LODAYA & ASSOCIATES Phone Number: 7021113226 COMPANY SECRETARY Email: csnuren@gmail.com (Peer Reviewed Firm) Registered Address: B 403, Pranav Commercial Plaza, MG Road, Mulund West, Mumbai 400080 SCRUTINIZER’S REPORT [Pursuant to Sections 108 and 110 of the Companies Act, 2013 read with Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014 and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015] The Chairman, Fischer Medical Ventures Limited CIN: L86900AP1993PLC118162 Survey No. 480/2, AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam – 530 032, Andhra Pradesh. Sub: Scrutinizer’s Report on Postal Ballot conducted through remote e-Voting pursuant to the Postal Ballot Notice dated 14th October, 2026 Dear Sir, I, CS Nuren Nirmal Lodaya, Proprietor of M/s. Nuren Lodaya & Associates, Practising Company Secretaries (FCS No. F14090, C.P. No. 24248), having office at B 403, Pranav Commercial Plaza, MG Road, Mulund West, Mumbai – 400 080, had been appointed as Scrutinizer by the Board of Directors of Fischer Medical Ventures Limited (CIN: L86900AP1993PLC118162) (“the Company”) at its meeting held on 14th October, 2026, pursuant to Rule 22(5) of the Companies (Management and Administration) Rules, 2014, as amended (“the Rules”), for conducting the Postal Ballot process through remote e-voting in a fair and transparent manner, in respect of the resolutions set out in the Postal Ballot Notice dated 14th October, 2026 (“the Notice”), pursuant to the provisions of Sections 108 and 110 of the Companies Act, 2013 (“the Act”) read with Rules 20 and 22 of the Rules, the General Circulars issued by the Ministry of Corporate Affairs (“MCA Circulars”), Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) and the Secretarial Standard on General Meetings (SS- The Management of the Company is responsible to ensure compliance with the requirements of the Act, the Rules, the MCA Circulars and the SEBI Listing Regulations relating to the Postal Ballot process and voting through electronic means on the resolutions contained in the Notice. My responsibility as Scrutinizer is restricted to scrutinising the remote e-voting process in a fair and transparent manner, and to making a Scrutinizer’s Report of the votes cast in favour of or against the resolutions. I submit my report as under: ● As per the information provided by the Company, the Notice, together with the Explanatory Statement, was sent on 16th October, 2026 through electronic mode to those Members whose names appeared in the Register of Members / List of Beneficial Owners as on the cut-off date, i.e. Friday, 09th October, 2026, and whose e-mail addresses were registered with the Company / Depositories, in accordance with Section 110 of the Act read with Rule 22 of the Rules and the MCA Circulars. The voting rights of the Members have been reckoned in proportion to their shareholding in the paid-up equity share capital of the Company as on the said cut-off date, one equity share carrying one vote. ● In terms of the Notice and the MCA Circulars, the voting on the resolutions was conducted only through remote e-voting and no physical postal ballot forms were sent or received. The Page 1 of 10 NUREN LODAYA & ASSOCIATES Phone Number: 7021113226 COMPANY SECRETARY Email: csnuren@gmail.com (Peer Reviewed Firm) Registered Address: B 403, Pranav Commercial Plaza, MG Road, Mulund West, Mumbai 400080 Company provided the facility of remote e-voting through the e-voting platform of National Securities Depository Limited (“NSDL”) under EVEN 143338. The remote e-voting period commenced on Saturday, 17th October, 2026 at 9:00 A.M. (IST) and ended on Sunday, 15th November, 2026 at 5:00 P.M. (IST), and the NSDL e-voting module was disabled thereafter. All the votes were cast within the said period. ● After the conclusion of the remote e-voting period, the votes cast through remote e-voting were unblocked and downloaded from the e-voting system of NSDL and scrutinised by me through the Scrutinizer’s login on the NSDL e-voting portal. ● The votes [Showing first 8,000 characters — download PDF for full document]